Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Mary Priyanka Udumula, Faraz Rashid, Harshit Singh…·Ramandeep Rattan
This study shows CPI-613 reduces tumor growth in chemoresistant ovarian tumors by inhibiting mitochondrial function and enhancing chemotherapy response.